"Looking forward: The antisense strategies being pioneered by companies like IONS are important for medicine, as they continue to demonstrate the proof that we can directly knock down protein expression as a treatment vector. For targets that cannot be drugged, this can represent an entirely emergent field of therapy, and if you had asked me five years
ago if we'll ever get it to work, I would have been skeptical, because of technical challenges and a history of failure for gene therapy. I am glad to see these early signs that the field is moving forward in a meaningful way!"
THe interest in ANTISENSE gathers pace...ANP in the box seat...but we really have to move on other projects quickly....
ANP Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)